CrushSCI.com
Journal Selection & Manuscript Polishing Services
INVESTIGATIONAL NEW DRUGS journal cover Medicine
Back to journal directory

Review Cycle Records

INVESTIGATIONAL NEW DRUGS

Springer SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 32025 JCR Q2
74.1Average days
69Median days
27Fastest days
160Longest days
1012025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

160 days

Recent progress of dendritic cell-derived exosomes in tumor immunotherapy

AuthorsBaiyan Wang; Yirui Hu; Yujia Zhou; Qianqian Han; Yu Huang; Yuanhang Dong; Yike Zhang; Zixuan Guo; Xuan Zhang; Shuying Feng

Affiliations1. Medical College, Henan University of Chinese Medicine, Zhengzhou, China; 2. Henan Engineering Research Center for Chinese Medicine Foods for Special Medical Purpose, Zhengzhou, China

Source PDF DOI Publisher page
73 days

Clinical pharmacokinetic characteristics and the food effect of radotinib

AuthorsYerin Lee; Jiwon Kim; Minseo Kang; Jiwon Han; Na Yun Kim; Jae Soo Shin; Min Soo Park; Qian Jiang; Jangik I. Lee

Affiliations1. College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea; 2. IL-YANG Pharmaceutical Co., Ltd, Yongin, Republic of Korea; 3. Department of Clinical Pharmacology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea; 4. Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China

Source PDF DOI Publisher page
63 days

Crocetin suppresses colorectal cancer progression by targeting TGM2 and inhibiting the JAK2/STAT3 pathway

AuthorsShuo Chen; Weijun Su; Kai Wang; Mingyue Xu; Binjie Su

Affiliations1. Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China; 2. Tianjin Institute of Coloproctology, Tianjin, China; 3. School of Medicine, Nankai University, Tianjin, China

Source PDF DOI Publisher page
61 days

Network pharmacology-based therapeutic intervention of Mentha arvensis targeting cancer and doxorubicin-induced cardiotoxicity

AuthorsSatinder Kaur; Umashanker Navik; Gurjit Kaur Bhatti; Jasvinder Singh Bhatti

Affiliations1. Laboratory of Translational Medicine and Nanotherapeutics, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, India; 2. Department of Pharmacology, Central University of Punjab, Bathinda, India; 3. Department of Medical Lab Technology, University Institute of Allied Health Sciences, Chandigarh University, Mohali, India; 4. University Centre for Research and Development, Chandigarh University, Mohali, India

Source PDF DOI Publisher page
69 days

Transforming cisplatin therapy: a localized, injectable poly(anhydride-ester) depot for safer and more effective head and neck cancer treatment

AuthorsOmiya Ali Hasan; Randa Mohammed Zaki; Obaid Afzal; Yasser Zaki; Mahmoud Omar; Amany A Abdel-Rheem

Affiliations1. Department of Pharmaceutics and Pharmaceutical Technology, Deraya University, Minia, Egypt; 2. Department of Pharmaceutics and Clinical Pharmacy, Sohag University, Sohage, Egypt; 3. Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj, Saudi Arabia; 4. Department of Pharmaceutics and Industrial Pharmacy, Beni-Suef University, Beni-Suef, Egypt; 5. Department of Pharmaceutical Chemistry, Prince Sattam Bin Abdulaziz University, Al Kharj, Saudi Arabia; 6. Yemen Ministry of HEALTH and Population, Sana’a, Yemen

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.